Zambia blasts the US over a $2 billion health deal in exchange for critical minerals
Zambia accuses the U.S. of linking a $2 billion health assistance deal to access to its rich mineral resources
another news portal
Zambia accuses the U.S. of linking a $2 billion health assistance deal to access to its rich mineral resources
For patients with Crohn’s disease or ulcerative colitis who have exhausted other treatment options, a new combination therapy is showing results that offer hope for
A new study led by researchers from VIB and KU Leuven shows that Parkinson’s disease can be divided into distinct subtypes, helping explain why a
In a Perspective published today in the inaugural issue of Brain Health (https://doi.org/10.61373/bh026p.0006), an international team of investigators argues that the human microplastic burden has
When the COVID-19 pandemic shut down clinics and forced face-to-face interactions behind masks, autism diagnoses for many children came to a halt.
The International Progressive MS Alliance announces the MS Clinical and Imaging Data Resource (MS CIDR) is now accepting applications for data access.
A cruise ship with nearly 150 people is waiting for help off Cape Verde’s coast in the Atlantic Ocean after three passengers died and three
A Closer Look at a Viral Claim The post Can Ivermectin and Mebendazole Treat Cancer? first appeared on Science-Based Medicine.
It turns out that Tweeting about RCTs 100+ times is a lot easier than delivering even a single RCT. The post Dr. Vinay Prasad Said
Alison Scott-Wright, also known as ‘The Magic Sleep Fairy’ has appeared on TV giving advice around improving the sleep of babies.
A researcher from the University of Kansas has led a large-scale study of university undergraduates to better understand how psychological conditions such as depression, anxiety
Climate change is likely to drive rodent-borne arenaviruses into parts of South America that have never faced these diseases, putting new communities of people at
Keratoconus is a progressive eye disease that weakens and thins the cornea, the clear front surface of the eye. In its early, subclinical stage, the
Mary Elizabeth Baugh, a research scientist with Virginia Tech’s Fralin Biomedical Research Institute at VTC, has been awarded a National Institutes of Health Mentored Research